BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 10882055)

  • 1. Potent adjuvant effect by anti-CD40 in collagen-induced arthritis. Enhanced disease is accompanied by increased production of collagen type-II reactive IgG2a and IFN-gamma.
    Tellander AC; Michaëlsson E; Brunmark C; Andersson M
    J Autoimmun; 2000 Jun; 14(4):295-302. PubMed ID: 10882055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down-regulation of Th1-mediated pathology in experimental arthritis by stimulation of the Th2 arm of the immune response.
    Mauri C; Feldmann M; Williams RO
    Arthritis Rheum; 2003 Mar; 48(3):839-45. PubMed ID: 12632440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interference with CD28, CD80, CD86 or CD152 in collagen-induced arthritis. Limited role of IFN-gamma in anti-B7-mediated suppression of disease.
    Tellander AC; Pettersson U; Runström A; Andersson M; Michaëlsson E
    J Autoimmun; 2001 Aug; 17(1):39-50. PubMed ID: 11488636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
    Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
    Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of murine collagen-induced arthritis with monoclonal anti-Ia antibodies and augmentation with IFN-gamma.
    Cooper SM; Sriram S; Ranges GE
    J Immunol; 1988 Sep; 141(6):1958-62. PubMed ID: 3139747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen-induced arthritis in DBA/1 mice: cytokine gene activation following immunization with type II collagen.
    Stasiuk LM; Abehsira-Amar O; Fournier C
    Cell Immunol; 1996 Nov; 173(2):269-75. PubMed ID: 8912886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of collagen-induced arthritis in mice by diesel exhaust particles.
    Yoshino S; Sagai M
    J Pharmacol Exp Ther; 1999 Aug; 290(2):524-9. PubMed ID: 10411558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activities of immunogenic collagen type II peptides in the induction of nasal tolerance to collagen-induced arthritis.
    Chu CQ; Londei M
    J Autoimmun; 1999 Feb; 12(1):35-42. PubMed ID: 10028020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis.
    Yoshioka T; Nakajima A; Akiba H; Ishiwata T; Asano G; Yoshino S; Yagita H; Okumura K
    Eur J Immunol; 2000 Oct; 30(10):2815-23. PubMed ID: 11069062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of Th2 cytokines and control of collagen-induced arthritis by nondepleting anti-CD4 Abs.
    Chu CQ; Londei M
    J Immunol; 1996 Sep; 157(6):2685-9. PubMed ID: 8805674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressive oligonucleotides protect against collagen-induced arthritis in mice.
    Dong L; Ito S; Ishii KJ; Klinman DM
    Arthritis Rheum; 2004 May; 50(5):1686-9. PubMed ID: 15146440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17.
    Chu CQ; Swart D; Alcorn D; Tocker J; Elkon KB
    Arthritis Rheum; 2007 Apr; 56(4):1145-51. PubMed ID: 17393396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High doses of interleukin-12 inhibit the development of joint disease in DBA/1 mice immunized with type II collagen in complete Freund's adjuvant.
    Hess H; Gately MK; Rüde E; Schmitt E; Szeliga J; Germann T
    Eur J Immunol; 1996 Jan; 26(1):187-91. PubMed ID: 8566065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epicutaneous immunization with type II collagen inhibits both onset and progression of chronic collagen-induced arthritis.
    Strid J; Tan LA; Strobel S; Londei M; Callard R
    PLoS One; 2007 Apr; 2(4):e387. PubMed ID: 17440622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of HLA-DR4 (0401) on the immune response to type II collagen and the development of collagen induced arthritis in mice.
    Wang D; Hill JA; Cairns E; Bell DA
    J Autoimmun; 2002 Mar; 18(2):95-103. PubMed ID: 11908942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment with an anti-IL-4 monoclonal antibody blocks suppression of collagen-induced arthritis in mice by oral administration of type II collagen.
    Yoshino S
    J Immunol; 1998 Mar; 160(6):3067-71. PubMed ID: 9510213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of a monoclonal antibody against interleukin-4 on collagen-induced arthritis in mice.
    Yoshino S
    Br J Pharmacol; 1998 Jan; 123(2):237-42. PubMed ID: 9489611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis.
    Morgan ME; Sutmuller RP; Witteveen HJ; van Duivenvoorde LM; Zanelli E; Melief CJ; Snijders A; Offringa R; de Vries RR; Toes RE
    Arthritis Rheum; 2003 May; 48(5):1452-60. PubMed ID: 12746920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longterm protection of mice against collagen-induced arthritis after short-term LF 15-0195 treatment: modulation of B and T lymphocyte activation.
    Ducoroy P; de Fornel D; Dubrez-Daloz L; Solary E; Dutartre P
    J Rheumatol; 2003 May; 30(5):918-25. PubMed ID: 12734883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engagement of the CD137 (4-1BB) costimulatory molecule inhibits and reverses the autoimmune process in collagen-induced arthritis and establishes lasting disease resistance.
    Foell JL; Diez-Mendiondo BI; Diez OH; Holzer U; Ruck P; Bapat AS; Hoffmann MK; Mittler RS; Dannecker GE
    Immunology; 2004 Sep; 113(1):89-98. PubMed ID: 15312139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.